XML 36 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:      
Net loss $ (67,592) $ (73,143) $ (175,383)
Adjustments to reconcile net loss to net cash provided by operating activities:      
Depreciation 8,301 10,464 11,374
Amortization of intangible assets 20,395 21,078 8,317
Amortization of capitalized internal-use software costs 18,486 20,739 28,863
Impairment of capitalized software 0 3,729 0
Amortization of debt discount and issuance costs 4,472 4,254 20,404
Amortization of deferred sales commission costs 40,181 38,195 34,701
Allowance for credit losses 2,236 1,892 1,974
Operating lease expense, net of accretion 10,934 12,030 13,482
Impairment of right-of-use assets 11,034 2,651 0
Stock-based compensation expense 61,910 89,536 133,331
(Gain) loss on debt extinguishment 1,766 (18,545) 0
Gain on remeasurement of warrants (2,176) (417) 0
(Gain) loss on sale of assets 179 (1,821) 0
Other 680 101 3,726
Changes in assets and liabilities:      
Accounts receivable, net 753 (8,450) 6,867
Deferred sales commission costs (22,879) (31,086) (44,224)
Other current and non-current assets (2,348) 2,150 (4,022)
Accounts payable and accruals (4,182) (24,403) (8,740)
Deferred revenue (3,165) (168) 4,010
Net cash provided by operating activities 78,985 48,786 34,680
Cash flows from investing activities:      
Purchases of property and equipment (2,650) (2,991) (4,137)
Proceeds from sale of intangible assets 0 1,000 0
Capitalized internal-use software costs (14,289) (11,896) (20,370)
Purchases of investments (6,174) (53,308) (83,383)
Sales of investments 0 8,296 13,299
Maturities of investments 31,659 66,199 60,023
Acquisition of businesses, net of cash acquired 0 (1,250) (125,410)
Net cash provided by (used in) investing activities 8,546 6,050 (159,978)
Cash flows from financing activities:      
Finance lease payments 0 0 (15)
Tax-related withholding of common stock 0 0 (310)
Proceeds from issuance of common stock under employee stock plans 4,884 4,679 16,107
Repurchase of capped calls 0 244 0
Repayment of principal on term loan (25,000) 0 0
Net proceeds from term loan 0 234,806 0
Repayment of convertible senior notes (63,295) (217,299) 0
Proceeds from issuance of convertible senior notes 0 0 134,619
Repurchase of common stock 0 (60,214) (44,976)
Net cash provided by (used in) financing activities (83,411) (37,784) 105,425
Effect of exchange rate changes on cash (126) (5,037) (585)
Net increase (decrease) in cash and cash equivalents 3,994 12,015 (20,458)
Cash, cash equivalents and restricted cash, beginning of year 112,729 100,714 121,172
Cash, cash equivalents and restricted cash, end of year 116,723 112,729 100,714
Supplemental and non-cash disclosures:      
Interest paid 35,574 22,162 2,156
Income taxes paid 5,974 1,530 1,320
Payables and accruals for property and equipment 3,868 38 88
Warrants issued in connection with term loan 0 5,915 0
Shares issued in connection with term loan and convertible senior notes 0 5,084 0
Issuance of 2028 convertible senior notes in exchange of 2024 convertible senior notes 0 201,914 0
Right-of-use assets acquired in connection with Fuze acquisition 0 0 7,261
Shares consideration in connection with Fuze acquisition 0 0 80,856
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:      
Cash and cash equivalents 116,262 111,400 91,205
Restricted cash, current 356 511 8,691
Restricted cash, non-current 105 818 818
Total cash, cash equivalents and restricted cash $ 116,723 $ 112,729 $ 100,714